Tasisulam (sodium)
Tasisulam is a anticancer agent and induces apoptosis via the intrinsic pathway, resulting in cytochrome c release and caspase-dependent cell death. Tasisulam inhibits mitotic progression and induces vascular normalization[1].
Product Specifications
CAS Number
519055-63-1
Product Name Alternative
LY 573636 (sodium)
UNSPSC
12352005
Target
Apoptosis
Type
Reference compound
Related Pathways
Apoptosis
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/tasisulam-sodium.html
Solubility
10 mM in DMSO
Smiles
O=C(N([Na])S(=O)(C1=CC=C(Br)S1)=O)C2=CC=C(Cl)C=C2Cl
Molecular Formula
C11H5BrCl2NNaO3S2
Molecular Weight
437.09
References & Citations
[1]Meier T, et al. Tasisulam sodium, an antitumor agent that inhibits mitotic progression and induces vascular normalization. Mol Cancer Ther. 2011 Nov;10 (11) :2168-78.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 2
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC882241-500 1x 500 µL
Glutathione S-Transferase Mu1 (GSTM1) (CPTC-GSTMu1-3), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details